Yeast study maps variant-specific effects of disease-linked mutations in RNA exosome subunit EXOSC3

A preprint deposited on bioRxiv describes a systematic functional comparison of pathogenic missense variants in EXOSC3 (also known as RRP40 in yeast), which encodes a structural cap subunit of the RNA exosome — an evolutionarily conserved ribonuclease complex that processes and degrades multiple classes of RNA. Mutations in genes encoding exosome subunits, including EXOSC3, have previously been associated with rare neurological disorders including pontocerebellar hypoplasia type 1b (PCH1b).

The authors introduced individual patient-derived variants into the yeast orthologue Rrp40 and assessed the functional consequences of each substitution, finding that variants differ meaningfully in the degree to which they impair exosome function. The results suggest that the clinical and mechanistic heterogeneity observed among patients carrying different EXOSC3 variants may reflect genuine variant-level differences in complex activity rather than a uniform loss-of-function mechanism.

The work illustrates the utility of yeast model systems for rapid, scalable interrogation of human disease variants at a gene that is difficult to study in mammalian cell lines at equivalent throughput. The authors note that findings in yeast require validation in more physiologically relevant systems before conclusions can be drawn about disease mechanism in human neurones. This is a preprint and has not yet completed peer review.